10192017Headline:

Montgomery, Alabama

HomeAlabamaMontgomery

Email Shannon Weidemann
Shannon Weidemann
Shannon Weidemann
Contributor •

Statins Work As Well As Vytorin

Comments Off

A new study just released has confirmed that Vytorin does not lower the risk of heart disease. Vytorin is a combination of a statin and a cholesterol lowering drug. The Enhance study showed that while Vytorin lowered cholesterol, it did not reduce plaque in arteries.

Doctors had embraced the drug because it does such a great job of lowering low-density lipoprotein, or LDL, the so-called bad cholesterol.

“Our strongest recommendation is that people need to go back to statins,” said Dr. Harlan Krumholz of Yale University, who spoke on behalf of the panel at the American College of Cardiology meeting in Chicago.

Statins have been prescribed by doctors for a long time and have a good history of lowering cholesterol. Vytorin is marketed by Merck and Scherling-Plough. Sales for Vytorin are over $5 Billion a year. Testing is still being performed to see if the drug has any harmful side effects. That study will be completed in 2012.